Triglyceride-glucose index predicts type 2 diabetes mellitus more effectively than oral glucose tolerance test-derived insulin sensitivity and secretion markers [0.03%]
甘油三酯-葡萄糖指数比口服葡萄糖耐量试验衍生的胰岛素敏感性和分泌标志物更有效地预测2型糖尿病
Min Jin Lee,Ji Hyun Bae,Ah Reum Khang et al.
Min Jin Lee et al.
Aims: We explored the role of the triglyceride-glucose (TyG) index as an early and superior predictor of type 2 diabetes mellitus (T2DM) in individuals with normal glucose tolerance (NGT) using a community-based Korean co...
Ongoing burden and recent trends in severe hospitalised hypoglycaemia events in people with type 1 and type 2 diabetes in Scotland: A nationwide cohort study 2016-2022 [0.03%]
苏格兰1型和2型糖尿病患者严重住院低血糖事件的持续负担及最近趋势：一项全国队列研究（2016-2022年）
William Berthon,Stuart J McGurnaghan,Luke A K Blackbourn et al.
William Berthon et al.
Aims: We examined severe hospitalised hypoglycaemia (SHH) rates in people with type 1 and type 2 diabetes in Scotland during 2016-2022, stratifying by sociodemographics. ...
Effects of long-term HbA1c variability on serious infection risks in patients with type 2 diabetes and the influence of age, sex and ethnicity: A cohort study of primary care data [0.03%]
糖化血红蛋白波动对2型糖尿病患者感染风险的影响：基于社区医疗数据的队列研究及年龄、性别和种族的修饰作用
Iain M Carey,Julia A Critchley,Umar A R Chaudhry et al.
Iain M Carey et al.
Aims: Long-term HbA1c (glycated haemoglobin) variability is associated with micro- and macrovascular complications in Type 2 diabetes (T2D). We explored prospective associations between HbA1c variability and serious infec...
Long-term lifestyle intervention can reduce the development of type 2 diabetes mellitus in subjects with prediabetes: A systematic review and meta-analysis [0.03%]
长期生活方式干预可减少糖尿病前期患者发展为2型糖尿病：系统评价和meta分析
Paula Portal Teixeira,Kelly Pozzer Zucatti,Lucas Strassburger Matzenbacher et al.
Paula Portal Teixeira et al.
Aims: To evaluate the effectiveness of intensive lifestyle intervention (ILI) on the risk of type 2 diabetes (T2D) in prediabetes (PD). Methods: ...
Remnant cholesterol is an independent risk factor for the incidence of chronic kidney disease in newly-diagnosed type 2 diabetes: A nationwide population-based study [0.03%]
剩余胆固醇是新诊断的2型糖尿病患者慢性肾脏病发病率的独立危险因素：一项基于全国人口的队列研究
Soo Yeon Jang,Minwoong Kang,Eyun Song et al.
Soo Yeon Jang et al.
Aims: To evaluate the impact of remnant cholesterol (remnant-C) on chronic kidney disease (CKD) incidence in newly-diagnosed type 2 diabetes. Methods: ...
International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes [0.03%]
国际糖尿病联盟关于诊断血糖异常和二型糖尿病的一小时餐后血浆葡萄糖值立场声明
Michael Bergman,Jaakko Tuomilehto
Michael Bergman
Major adverse events in youth-onset type 1 and type 2 diabetes: The SEARCH and TODAY studies [0.03%]
青少年发病的1型和2型糖尿病的重要不良事件：SEARCH和TODAY研究
Amy K Mottl,Jeanie B Tryggestad,Scott Isom et al.
Amy K Mottl et al.
Aims: To determine contemporary incidence rates and risk factors for major adverse events in youth-onset T1D and T2D. Methods: Particip...
The effect of subcutaneous Lixisenatide on weight loss in patients with type 2 Diabetes Mellitus: Systematic review and Meta-Analysis of randomized controlled trials [0.03%]
系统综述和随机对照试验的Meta分析：GLP-1受体激动剂利西拉来对二型糖尿病患者减轻体重的影响
Lei Sheng,Meixian Deng,Xin Li et al.
Lei Sheng et al.
Background: The impacts of subcutaneous Lixisenatide on body weight in patients with type 2 DM, remain inadequately understood; consequently, this systematic review and meta-regression analysis of randomized controlled tr...
Not enough known about fenofibrate's kidney effects in people with Type 2 diabetes [0.03%]
对于二型糖尿病患者尚不清楚非诺贝特对肾脏的影响
Alicia J Jenkins,Rachel L O&#x;Connell,Andrzej S Januszewski et al.
Alicia J Jenkins et al.
Globally ≈10% of adults have diabetes, with 80% in disadvantaged regions, hence low-cost renoprotective agents are desirable. Fenofibrate demonstrated microvascular benefits in several cardiovascular end-point diabetes trials, but knowledg...